REGENESIS BIOMEDICAL, INC.
SCOTTSDALE, AZ

Recovery was painful. With the help of Provant helped me recover, gave me hope, and made rehabilitation quicker and less painful." Company Description Regenesis Biomedical Regenesis Biomedical is a device company dedicated to improving human welfare through the research, design, manufacture, and sale of energy-based medical products and services that alleviate pain, restore health, and improve quality of life. As a company we value dedication, innovation, integrity, respect, excellence, compassion and teamwork. Our customers include health care facilities and providers that serve patients treated in acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, and outpatient clinics, as well as by patients in their homes under physician orders. Company Structure Regenesis Biomedical, Inc. was founded in 1997 as a Delaware C corporation. The Company is privately held and current investors include venture capital firms, management and private investors. Provant is a medical device that decreases the pain and swelling associated with operative procedures, helping tissue move through, and out of, inflammation. Provant also reduces pain by inducing endogenous opioids. Mr. Brooks is President, Chief Executive Officer, and on the Board of Directors. Scott joined Regenesis Biomedical in January 2012 as the Chief Operating Officer. He has held senior executive positions in four major healthcare organizations. Scott has extensive experience in sales, marketing, and operations. Prior to Regenesis he held the position of President in the U.S. and Canada for BSN Medical located in Charlotte, NC. At BSN Scott was instrumental in developing sales, expanding clinical education programs, and enhancing management development. Prior to BSN, Scott was the VP of Sales and National Accounts for Kinetic Concepts Inc. (KCI), the global leader of advanced wound care devices. During his tenure at KCI, he held senior leadership positions in five different divisions of the company. KCI’s broad device portfolio includes therapy devices designed for advanced wound care, critical care and bariatric care, sold throughout the continuum of care. Scott served on the senior management team as the company emerged into the innovative global leader in advance wound care. He was also instrumental in two mergers and acquisitions, plus negotiated and implemented numerous strategic contracts and alliances. Scott’s experience also includes successful leadership positions with The Hill-Rom Company and Kimberly-Clark Healthcare. Mr. Brooks earned a Bachelor of Arts in Business Administration from Western Washington University. Mr. Genge joined Regenesis Biomedical in early 2007. During his 35 year career, he has held senior financial executive positions in 4 public and 2 private companies, with a particular emphasis in startup companies who experienced rapid growth, initial product approvals and commercial launches in the medical device, life sciences and health care service industries. In particular, Mr. Genge has directed a Sarbanes Oxley compliance program, taken 2 companies through their initial IPO’s, completed numerous public and private equity and debt offerings, negotiated and implemented multiple strategic alliances with major pharmaceutical companies, managed the merger and acquisition of 6 companies, been responsible for directing the reporting for SEC compliance reporting, managed HR, IT, purchasing, insurance, and facilities operations and directed the implementation of major financial systems. Prior to Regenesis Mr. Genge was a Partner with Tatum, LLC, a Financial Services Practice. Prior to that, he served as Vice-President, CFO and Treasurer of Novavax Inc, a public life sciences company. Before Novavax Dennis was Vice-President and Controller at Pyxis Corporation (a subsidiary of Cardinal Health), a medical supply stations company. He also served as Executive Director of Finance and Corporate Controller at Ligand Pharmaceuticals, a biotechnology company, Vice-President and CFO of Ivonyx HomeCare Services, an IV home therapy company and Executive Director/Controller with IMED Corp. an IV pump company. Mr. Genge began his career as an auditor with Ernst and Young in San Diego. Mr. Genge obtained his CPA license in the state of California and holds a Masters of Business Administration and a Bachelor of Administration with an emphasis in Accounting from Western Michigan University. Mr. Robey is a 20+ year marketing veteran. Prior to Regenesis he served as Senior Director of Marketing at Kinetic Concepts, Inc (KCI) for the V.A.C. Therapy brand during the time US product sales grew from about $70M in 2000 to about $1 billion by 2007. He has held marketing positions at Medtronic, Sulzer Carbomedics, and Burron Medical (B. Braun Medical, Inc). His responsibilities have included product management, new product development and commercialization, branding, clinical education programs, and key opinion leader and society relationship development. Mr. Robey has an M.S. in Management from Purdue University, and a B.S. in Biomedical Engineering from Louisiana Tech University. John Moffett, Ph.D., joined Regenesis Biomedical in 2003. Dr. Moffett’s research experience includes study at Dana Farber Cancer Institute and The Salk Institute for Biological Studies. His main research focus has been in understanding how biological events and processes are regulated, especially at the molecular and cellular levels. Dr. Moffett’s background is multifaceted and includes hands-on experimental work on a range of biomedical topics, including nutrient metabolism, somatic cell genetics, gene regulation, and protein modulation. His recent studies with Regenesis Biomedical have focused on the understanding of the effects of electromagnetic fields on biological systems. Dr. Moffett attained his B.A. and Ph.D. from the University of California at Santa Barbara. Richard D. Shirk has more than 30 years of experience in insurance, employee benefits, and healthcare, and over 20 years experience in investment management. Currently he serves on the Board of Directors of Amerigroup. Previously he served as President, CEO and Chairman of Cerulean Companies, the holding company of Blue Cross Blue Shield of Georgia, and as President and CEO of Blue Cross Blue Shield of Georgia. Mr. Shirk also held senior officer positions with The Equitable Life Assurance Society, Equicor, and Cigna. He serves on the Board of the Metro Atlanta YMCA, the Woodruff Arts Center and its investment committee, and is a member of the Society of International Business Fellows. He is a Trustee Emeritus of Gettysburg College and has recently completed service on the Board of the Southeastern Region American Red Cross Blood Services and as Chair of the American Red Cross Metro Atlanta Chapter Board. He is a graduate of Gettysburg College.